56
8
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1880 |
P7C3
|
Others | Others |
P7C3 是一种 aminopropyl carbazole 类化合物,具有口服活性,可透过血脑屏障,具有神经保护作用。它可用于神经退行性疾病,如帕金森病的研究。 | |||
T8849 |
PF-9601N
|
MAO | Metabolism; Neuroscience |
PF-9601N 是一种单胺氧化酶 B (MAO-B) 抑制剂,在多种体内外模型中表现出抗帕金森病 (PD) 的神经保护作用。它可用于研究兴奋性毒性介导的神经退行性疾病。 | |||
T22043 |
BCATc Inhibitor 2
|
Others | Others |
BCATc Inhibitor 2 是选择性分支链氨基转移酶抑制剂,可用于神经退行性疾病的研究。能够抑制 rBCATc (IC50:0.2 μM),hBCATc (IC50:0.8 μM)、 rBCATm (IC50:3.0 μM)。其中BCATc 也称为 BCAT1,存在于细胞质基质中的亚型。 | |||
T11095L |
DREADD agonist 21
|
5-HT Receptor; Adrenergic Receptor; AChR; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
DREADD agonist 21 是一种人毒蕈碱乙酰胆碱 M3 受体激动剂,EC50为 1.7 nM。 | |||
T9611 |
PF-04802367
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
PF-04802367是 GSK-3高选择性抑制剂,对 GSK-3β酶的 IC50为 2.1 nM。它抑制两种 GSK-3 亚型(GSK-3α和GSK-3β)效果差不多,IC50值分别为 10.0 和 9.0 nM。它具有理想的中枢神经系统特性和效力。 | |||
T6561 |
Laquinimod
LAQ,ABR-215062,拉喹莫德 |
Apoptosis; Others; NF-κB | Apoptosis; NF-κB; Others |
Laquinimod (LAQ) 是一种免疫调节剂,可预防中枢神经系统的神经变性和炎症。 | |||
T9999 |
Sirtuin modulator 2
N-(3-(imidazo[2,1-b]thiazol-6-yl)phenyl)-2-methoxybenzamide |
Others; Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair; Others |
Sirtuin modulator 2 (N-(3-(imidazo[2,1-b]thiazol-6-yl)phenyl)-2-methoxybenzamide) 具有抗糖尿病、抗炎和抗肿瘤活性。 | |||
T8055 |
TFEB activator 1
(1E,4E)-1,5-Bis(2-Methoxyphenyl)penta-1,,Curcumin analog compound C1,Curcumin analog C1,(1E,4E)-1,5(2 -甲氧基苯基)-1,4-戊二烯-3-酮,RPN77612 |
Others; Autophagy | Autophagy; Others |
TFEB activator 1 (Curcumin analog compound C1) 是转录因子 EB 的一种激活剂,有望预防或治疗阿尔茨海默病。 | |||
T77708 |
Casein kinase 1δ-IN-7
|
Casein Kinase | Metabolism; Stem Cells |
Casein kinase 1δ-IN-7 是一种 Casein kinase 1δ 抑制剂,可用于阿尔茨海默氏病等神经退行性疾病的研究。 | |||
T77709 |
Casein kinase 1δ-IN-8
|
Casein Kinase | Metabolism; Stem Cells |
Casein kinase 1δ-IN-8 是一种酪蛋白激酶 1δ 的抑制剂,可用于治疗如阿尔茨海默病类型的神经退行性疾病。 | |||
T62568 |
IXA6
|
IRE1 | Cell Cycle/Checkpoint |
IXA6 是一种新型的IRE1/XBP1s激动剂,具有潜在的血管保护活性,可激活 IRE1-XBP1s 信号传导和 XBP1s 转录反应,可用于研究帕金森病和阿尔茨海默病等神经退行性疾病。 | |||
T5447 |
Anle138b
|
Beta Amyloid; Others | Neuroscience; Others |
Anle138b 是一种毒性低,口服生物利用度高,血脑屏障通透性好的低聚物聚集抑调节剂,可阻断朊病毒蛋白和 α-突触核蛋白病理性聚集的形成。它在体内强烈抑制低聚物积累、神经元变性和疾病进展。它阻断 Aβ 通道并挽救淀粉样变性小鼠模型的疾病表型。 | |||
T60295 |
Casein kinase 1δ-IN-1
WAY-643895 |
Casein Kinase | Metabolism; Stem Cells |
Casein kinase 1δ-IN-1 (WAY-643895) 是一种酪蛋白激酶 1δ (CK1δ) 的抑制剂,对CK1δ有抑制作用。Casein kinase 1δ-IN-1 可用于如阿尔茨海默病类的神经退行性疾病的研究。 | |||
T61809 |
GSK-3β inhibitor 11
|
GSK-3 | PI3K/Akt/mTOR signaling; Stem Cells |
GSK-3β inhibitor 11(compound 21)是一种强效的糖原合成酶激酶-3β(GSK-3β)抑制剂,其抑制浓度(IC50)为10.02 μM。该化合物在神经退行性疾病研究领域展示了潜在的应用价值[1]。 | |||
T16881L |
SIB 1553A
|
AChR | Neuroscience |
SIB 1553A 是一种可口服且具有选择性的烟碱乙酰胆碱受体 (nAChRs) 激动剂,是烟碱乙酰胆碱受体的亚型选择性配体。SIB-1553A 是一种认知增强剂,可用于研究如阿尔茨海默病等与神经退行性相关的疾病。 | |||
T61439 |
DSS30
|
Beta Amyloid; BACE; CDK | Cell Cycle/Checkpoint; Neuroscience |
DSS30 是一种 P25/CDK5抑制剂。DSS30通过抑制淀粉样前体蛋白裂解酶1 (BACEl) 磷酸化,减少 β-淀粉样蛋白 (Aβ) 的分泌发挥作用。DSS30 可用于预防和治疗阿尔茨海默病等神经退行性疾病。 | |||
T1993 |
J-147
J147 |
Epigenetic Reader Domain; Dopamine Receptor; Monoamine Oxidase | Chromatin/Epigenetic; GPCR/G Protein; Neuroscience |
J-147 是一种高效的、具有口服活性的、可透过血脑屏障神经保护剂,可增强认知能力。它抑制单胺氧化酶 B 和多巴胺转运体,EC50分别为 1.88 μM 和 0.649 μM。它有研究阿尔茨海默氏症的潜力。 | |||
T63321 |
20S Proteasome activator 1
|
Proteasome | Proteases/Proteasome; Ubiquitination |
20S Proteasome activator 1 是一种 20S 蛋白酶激活剂,对胰蛋白酶样位点、胰凝乳蛋白酶样位点和半胱天冬酶位点的 IC50 分别为 0.3 μM、0.7 μM 和 1.8 μM。20S Proteasome activator 1 通过在细胞系统中翻译来防止致病性 α-synuclein A53T 突变体积累从而减少疾病发生的概率。20S Proteasome activator 1 可用于研究神经退行性疾病。 | |||
T40766 |
1,2,3,4-Tetrahydro-β-carboline-1-carboxylic acid
|
||
1,2,3,4-Tetrahydro-β-carboline-1-carboxylic acid is a neuroactive compound utilized in neurodegenerative disease research. | |||
T61662 |
O-GlcNAcase-IN-4
|
||
O-GlcNAcase-IN-4 is an inhibitor of O-GlcNAcase. It holds potential for researching neurodegenerative diseases and disorders, including Alzheimer's disease [1]. | |||
T68950 | Hepta-histidine | ||
Hepta-histidine is a novel inhibitor of Tau aggregation against Tau-related neurodegenerative diseases including Alzheimer's disease (AD). | |||
TP1320 |
Angiogenin (108-122) TFA (112173-49-6 free base)
Angiogenin (108-122) TFA |
||
Angiogenin (108-122) TFA is an angiogenin peptide.Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmu | |||
TP1362 |
Angiogenin (108-122)
Angiogenin 108-122 |
||
Angiogenin (108-122) is an angiogenin peptide. Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune | |||
T30266 |
AZD8926
AZD 8926,AZD-8926 |
||
AZD8926 is a potent and selective inhibitor of GSK3β(glycogen synthase kinase-3β). AZD8926 is potential for treating Alzheimer’s disease (AD), schizophrenia, and chronic as well as acute neurodegenerative diseases. | |||
T77610 |
WAY-339495
|
Others | Others |
WAY-339495 可能具有抗肿瘤抗炎和镇痛活性,可用来研究肥胖、心血管疾病、糖尿病、神经退行性疾病、阿尔茨海默病和中风。 | |||
T75751 |
β-Amyloid (1-40) (TFA)
|
||
β-Amyloid (1-40) TFA 是阿尔茨海默症患者脑斑块中发现的一种主要蛋白片段。 | |||
T79857 |
Risevistinel
NYX-783 |
iGluR | Membrane transporter/Ion channel; Neuroscience |
Risevistinel (NYX-783),一种N-甲基-D-天冬氨酸 (NMDA) 受体正变构调节剂,旨在缓解与神经退行性疾病相关的认知功能障碍,包括轻度认知障碍、阿尔茨海默病初期、帕金森病及路易体病等病症。 | |||
T79855 |
Nevadistinel
NYX-458,NYX-3054 |
iGluR | Membrane transporter/Ion channel; Neuroscience |
Nevadistinel (NYX-458; NYX-3054) 是一种NMDA受体的正变构调节剂,主要应用于抑制与神经退行性疾病相关的认知障碍,疾病包括轻度认知障碍、轻度阿尔茨海默病、帕金森病和路易体病。 | |||
TP2069 |
BDNF (human)
|
||
Member of the neurotrophin growth factor family that binds and activates TrkB and p75 neurotrophin receptors. Enhances the survival, growth and differentiation of neurons. BDNF expression is altered in neurodegenerative disorders such as Parkinson's and A | |||
T61128 | c-ABL-IN-2 | ||
C-ABL-IN-2 is a highly effective inhibitor of the c-Abl protein, which plays a significant role in the development of several diseases, including cancer. This compound exhibits promise for investigating neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), as well as cancer. (Source: WO2020260871A1, compound 25) [1]. | |||
T62534 | POP-IN-2 | ||
POP-IN-2 (Compound 7k) 是一种有效的、共价结合的 prolyl oligopeptidase (POP) 抑制剂 (Ki: 6 nM)。POP-IN-2 能够用于神经退行性疾病和癌症的研究。 | |||
T80118 |
α-Synuclein (61-95) (human)
|
||
α-Synuclein(61-95) (human) 是 α-Synuclein 的疏水核心区段,具有诱导神经元死亡的能力。该肽段在神经退行性疾病的研究中有应用,涉及阿尔茨海默病 (AD) 与帕金森病 (PD)。 | |||
T74097 | THX-B | ||
THX-B为一高效非多肽类p75NTR(神经营养蛋白受体p75)拮抗剂,适用于糖尿病、肾病、神经退行性及炎症性疾病研究。 | |||
T61546 |
c-ABL-IN-3
|
||
c-ABL-IN-3, a highly effective c-Abl inhibitor, exhibits promising potential for studying neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), as well as cancer [1]. The activation of c-Abl has been strongly implicated in a range of diseases, notably cancer [1]. It offers valuable opportunities for research in these fields [1]. | |||
T60591 |
A2AAR antagonist 1
|
||
A2AAR antagonist 1 (compound 21a) 是A2AAR(腺苷A2A 受体) 的拮抗剂,具有高配体效率,Ki 值为 20 nM。A2AAR antagonist 1 可用于神经退行性疾病的相关研究。 | |||
TP1673 |
β-Amyloid (11-22)
β-Amyloid 11-22 |
||
β-Amyloid (11-22) is a peptide fragment of β-Amyloid.Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer’s patients, is thought to be the cause of Alzheimer’s Disease (AD). AD is the most common neurodegenerat | |||
T81251 |
rTRD01
|
||
rTRD01为TDP-43配体,与TDP-43的RRM1和RRM2结构域结合(Kd=89 uM,TDP-43102-269)。该化合物能够削弱TDP-43与与疾病相关的c9orf72基因的六核苷酸RNA的交互作用,可作为神经退行性疾病研究的工具。 | |||
T81820 |
meso-Benzothiazole-BODIPY 505/515
|
||
meso-Benzothiazole-BODIPY 505/515 是一种BODIPY荧光探针,具备优异的粘度反应性及AIE特性,能够监测细胞内粘度变化与自噬过程。该探针适用于阿尔茨海默病、溶酶体贮积病以及其他神经退行性疾病的研究。 | |||
T60824 | Dyrk1A-IN-3 | ||
Dyrk1A-IN-3 (Compound 8b) 是双特异性酪氨酸调节激酶 1A (DYRK1A) 的高选择性抑制剂。Dyrk1A-IN-3与 DYRK1A 结合具有高结合亲和力,IC50值为76 nM。Dyrk1A-IN-3可用于研究神经退行性疾病,例如,阿尔茨海默病、亨廷顿病和帕金森病等。 | |||
T79010 | Lp-PLA2-IN-12 | Phospholipase | Metabolism |
Lp-PLA2-IN-12(compound 19)为一种Lp-PLA2抑制剂,主要应用于神经退行性疾病(如AD、青光眼、AMD)及心血管疾病(诸如动脉粥样硬化)的研究。 | |||
T79333 |
LZWL02003
|
Reactive Oxygen Species | Immunology/Inflammation; Metabolism; NF-κB |
LZWL02003为抗神经炎症化合物,对MPP+引起的神经元损害展示保护效果,有效降低ROS水平。此外,LZWL02003能改善鱼藤酮诱导的帕金森病(PD)大鼠模型在认知、记忆、学习及运动能力方面的缺陷。该化合物在神经退行性疾病的研究中具有应用潜力。 | |||
T79154 |
Casein kinase 1δ-IN-5
|
Casein Kinase | Metabolism; Stem Cells |
Casein kinase1δ-IN-5为一种高效的蛋白激酶CK-1δ选择性抑制剂,IC50值为47 nM。该化合物在体外展现出神经保护和抗炎效果,具备应用于神经退行性疾病研究的潜力。 | |||
T35804 | C16 Lactosylceramide (d18:1/16:0) | ||
C16 Lactosylceramide is an endogenous bioactive sphingolipid. It forms membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs), suggesting a role in cell signaling. Plasma levels of C16 lactosylceramide are elevated in insulin-resistant cattle. C16 Lactosylceramide is also upregulated in a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder. | |||
T35809 |
C20 Sphingomyelin (d18:1/20:0)
|
||
C20 Sphingomyelin is a naturally occurring sphingolipid. Levels of C20 sphingomyelin are upregulated in the hippocampus of rats with diabetes induced by streptozotocin and in human plasma where it is positively correlated with insulin resistance in obese humans. C20 sphingomyelin is also upregulated in the liver of a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder. The plasma concentration of C20 sphingomyelin is decreased in m... | |||
T62612 | CD33 splicing modulator 1 | ||
CD33 splicing modulator 1 (Compound 1) 是一种 CD33 splicing modulator。CD33/Siglec 3 是一种已知可调节小胶质细胞活性的髓系细胞表面受体。CD33 splicing modulator 1 加强了细胞 mRNA 池中外显子 2 的跳跃。CD33 splicing modulator 1 具有潜力进行包括阿尔茨海默病在内的神经退行性疾病的研究。 | |||
T78833 | AJH-836 | PKC | Chromatin/Epigenetic; Cytoskeletal Signaling |
AJH-836为Munc13-1及PKCε/α激活剂(Kd:4.5 nM PKCα),促进Munc13-1由细胞质转位至质膜,并可应用于神经退行性疾病研究。 | |||
T35594 |
Cuspin-1
|
||
The Survival of Motor Neurons (SMN) protein participates in RNA splicing. Decreases in SMN, typically a consequence of defects in the smn1 gene, result in the death of motor neurons and lead to the neurodegenerative disease, spinal muscular atrophy (SMA). Cuspin-1 is a small molecule upregulator of SMN that has been shown in vitro to increase levels of SMN in SMA patient fibroblasts by 50% at 18 μM. Its mechanism of action is thought to involve increased phosphorylation of ERK to initiate Ras-Ra... | |||
T80106 |
Z-Pro-Pro-aldehyde-dimethyl acetal
|
Prolyl Endopeptidase (PREP) | Metabolism; Proteases/Proteasome |
Z-Pro-Pro-aldehyde-dimethyl acetal 是一种高效的脯氨酸内肽酶(PRE P)抑制剂,其IC50值为12 nM。该化合物在衰老过程和神经退行性疾病,诸如阿尔茨海默病中认知功能障碍的研究中具有重要作用。 | |||
T82763 |
CD33 splicing modulator 1 hydrochloride
|
||
"CD33splicing modulator 1 (Compound 1) hydrochloride 是一种调节CD33/Siglec 3活性的化合物。CD33/Siglec 3 为髓系细胞表面受体,涉及小胶质细胞功能。该化合物通过提升细胞mRNA池中外显子2的剪接变异,展现在神经退行性疾病研究中的应用潜力,包括阿尔茨海默病。" | |||
T73289 | mHTT-IN-1 | ||
mHTT-IN-1 (Example 1) 为针对突变亨廷顿蛋白 (mHTT) 的高效抑制剂,该蛋白具毒性,主导遗传性常染色体显性神经退行性疾病—亨廷顿氏病 (HD) 的发生。mHTT-IN-1 能有效降低 mHTT 水平,其 EC50 值为 0.46 nM。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21883 |
Gedunin
|
HSP | Cytoskeletal Signaling; Metabolism |
Gedunin 是从印楝种子中提取的一种重要柠檬苦素,具有抗癌、抗病毒、抗炎和杀虫活性。它可阻断 SARS-CoV-2 病毒进入人宿主细胞,用于 COVID-19 研究。它是Hsp90抑制剂,诱导 Hsp90 依赖的蛋白降解,抑制卵巢癌细胞增殖。 | |||
T0086 |
Galanthamine hydrobromide
Galantamine hydrobromide,Galanthamine HBr,氢溴酸加兰他敏 |
AChR; AChE | Neuroscience |
Galanthamine hydrobromide (Galantamine hydrobromide) 是一种长效的中枢活性 AChE 抑制剂,IC50为 410 nM。它是神经元烟碱型 ACh 受体的变构增强剂,IC50值为 0.35 µM,可用于阿尔茨海默症的研究。 | |||
T3026 |
(-)-Huperzine A
HupA,石杉碱,Huperzine A,石杉碱甲 |
Apoptosis; AChR; AChE; iGluR | Apoptosis; Membrane transporter/Ion channel; Neuroscience |
(-)-Huperzine A (HupA) 是从中国梅花苔中分离得到的一种生物碱,具有神经保护活性。它是高特异性可逆的,具有血脑屏障渗透性的一种乙酰胆碱酯酶抑制剂, 其IC50值为 82 nM。 它也是 N-甲基-D-天冬氨酸受体的非竞争性拮抗剂,可研究神经退行性疾病,如阿尔茨海默病。 | |||
T4956 |
Tetrahydroxystilbene-2-O-β-D-glucoside
tetrahydroxyl diphenylethylene-2-o-gluco,何首乌苷,EH-201 |
Others | Others |
Tetrahydroxystilbene-2-O-β-D-glucoside (EH-201) 是一种低分子量的促红细胞生成素诱导剂。 | |||
T4S0797 |
Berberine
小檗碱,Berberin,Umbellatine,黄连素 |
Reactive Oxygen Species; Topoisomerase; Endogenous Metabolite; Antibacterial; Antibiotic; Autophagy | Autophagy; DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism; Microbiology/Virology; NF-κB |
Berberine (Umbellatine) 是从中草药黄连中分离出来的一种生物碱抗生素。它诱导活性氧生成并抑制 DNA 拓扑异构酶,具有抗肿瘤特性。 | |||
T2S2215 |
Crebanine
|
Apoptosis; Others; Akt | Apoptosis; Cytoskeletal Signaling; Others; PI3K/Akt/mTOR signaling |
Crebanine 是来自于韦诺萨千金藤的一种生物碱,通过抑制 MAPKs 和 Akt 信号通路表现出抗炎活性,还具有抗心律失常的作用。它可诱导人类癌细胞的 G1阻滞和凋亡。 | |||
T38606 | Sinapine hydroxide | ||
Sinapine hydroxide, an alkaloid derived from the seeds of cruciferous plants, demonstrates a variety of beneficial properties including anti-inflammatory, anti-oxidant, anti-tumor, anti-angiogenic, and radio-protective effects. Additionally, it acts as an inhibitor of acetylcholinesterase (AChE), making it valuable for researching neurodegenerative conditions such as Alzheimer’s disease, ataxia, myasthenia gravis, and Parkinson’s disease[4]. | |||
T75527 | Chrexanthomycin C | ||
Chrexanthomycin C 是一种具有显著生物活性的海洋天然产物,具有口服活性。Chrexanthomycin C 对 DNA (G4C2)4 G4 具有结合亲和力,Kd 值为 2.8 mM。Chrexanthomycin C 可用于肌萎缩侧索硬化症 (ALS) 等神经退行性疾病的研究。 |